We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+4.12%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$12.8B
AUM Growth
+$248M
Cap. Flow
+$26.2M
Cap. Flow %
0.2%
Top 10 Hldgs %
17.81%
Holding
1,065
New
31
Increased
380
Reduced
425
Closed
21

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$71.7M
2
RAI
Reynolds American Inc
RAI
+$44.4M
3
CF icon
CF Industries
CF
+$20.3M
4
ELV icon
Elevance Health
ELV
+$17.8M
5
INTC icon
Intel
INTC
+$12.3M

Sector Composition

Rank Sector Weight
1 Financials 16.72%
2 Healthcare 16.7%
3 Technology 15.85%
4 Communication Services 11.37%
5 Consumer Discretionary 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMD icon
526
ResMed
RMD
$30.7B
$2.27M 0.02%
30,360
-232
-0.8% -$17.7K
STI
527
DELISTED
SunTrust Banks, Inc.
STI
$2.26M 0.02%
37,557
-2,471
-6% -$140K
EQT icon
528
EQT Corp
EQT
$32.3B
$2.26M 0.02%
66,648
-524
-0.8% -$17.8K
DVN icon
529
Devon Energy
DVN
$47.3B
$2.24M 0.02%
71,035
-53,768
-43% -$1.74M
ANET icon
530
Arista Networks
ANET
$238B
$2.24M 0.02%
203,712
-62,016
-23% -$649K
PBR icon
531
Petrobras
PBR
$116B
$2.23M 0.02%
258,100
ADSK icon
532
Autodesk
ADSK
$52.6B
$2.21M 0.02%
19,336
-3,670
-16% -$405K
EHC icon
533
Encompass Health
EHC
$12.4B
$2.21M 0.02%
62,724
+6,033
+11% +$215K
ACAD icon
534
Acadia Pharmaceuticals
ACAD
$5.03B
$2.16M 0.02%
68,900
PRAH
535
DELISTED
PRA Health Sciences, Inc.
PRAH
$2.16M 0.02%
28,750
WCG
536
DELISTED
Wellcare Health Plans, Inc.
WCG
$2.16M 0.02%
12,360
-1,239
-9% -$217K
PCAR icon
537
PACCAR
PCAR
$70.1B
$2.15M 0.02%
48,495
-861
-2% -$38.8K
IQV icon
538
IQVIA
IQV
$39.3B
$2.15M 0.02%
22,669
-1,273
-5% -$118K
SKM icon
539
SK Telecom
SKM
$13.2B
$2.14M 0.02%
49,276
SSYS icon
540
Stratasys
SSYS
$774M
$2.13M 0.02%
97,500
+15,500
+19% +$358K
KITE
541
DELISTED
Kite Pharma, Inc.
KITE
$2.13M 0.02%
16,650
LII icon
542
Lennox International
LII
$15.2B
$2.11M 0.02%
12,374
+2,136
+21% +$368K
IVZ icon
543
Invesco
IVZ
$13.9B
$2.1M 0.02%
59,235
-963
-2% -$32.9K
LXRX icon
544
Lexicon Pharmaceuticals
LXRX
$1.1B
$2.08M 0.02%
143,441
TECH icon
545
Bio-Techne
TECH
$11.3B
$2.07M 0.02%
69,840
BIO icon
546
Bio-Rad Laboratories Class A
BIO
$9.42B
$2.06M 0.02%
9,600
MHK icon
547
Mohawk Industries
MHK
$9.22B
$2.05M 0.02%
7,846
+896
+13% +$223K
ISBC
548
DELISTED
Investors Bancorp, Inc.
ISBC
$2.05M 0.02%
157,200
+8,700
+6% +$115K
CBI
549
DELISTED
Chicago Bridge & Iron Nv
CBI
$2.05M 0.02%
205,773
+64,400
+46% +$986K
CPRT icon
550
Copart
CPRT
$27.5B
$2.05M 0.02%
254,472
-70,400
-22% -$564K

Similar funds

DekaBank Deutsche Girozentrale's Q3 2017 Portfolio in Review

As of Q3 2017, DekaBank Deutsche Girozentrale held 1,065 positions worth $12.8B, up 2% from $12.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 4.9%. DekaBank Deutsche Girozentrale opened 31 new positions and exited 21, leaving the 1,065-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Technology.

  • DekaBank Deutsche Girozentrale's largest Q3 2017 buy was British American Tobacco: 300,882 shares worth $18.8M.
  • DekaBank Deutsche Girozentrale added most to Goldcorp Inc in Q3 2017, an estimated $22.1M increase.
  • DekaBank Deutsche Girozentrale's biggest Q3 2017 reduction was Deutsche Bank, cutting an estimated $71.7M.
  • DekaBank Deutsche Girozentrale fully exited Reynolds American Inc in Q3 2017, selling an estimated $44.4M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 18% of its $12.8B portfolio in Q3 2017.
  • DekaBank Deutsche Girozentrale opened 31 new positions and closed 21 in Q3 2017.
  • DekaBank Deutsche Girozentrale's portfolio value rose 2% quarter-over-quarter to $12.8B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2017, filed 6 Nov 2017.